Literature DB >> 12118386

Issues in optimization for planning of intensity-modulated radiation therapy.

Lynn J Verhey1.   

Abstract

The clinical use of intensity-modulated radiation therapy (IMRT) is expanding rapidly in academic and, more recently, in community-based radiotherapy centers due to a high level of clinician interest, improving reimbursement patterns, and the availability of the tools required to plan and deliver IMRT plans. These tools include inverse planning optimization algorithms and linear accelerator control systems with automated, multifield delivery capabilities. The hazards of this new technology are due primarily to the nonintuitive nature of the inverse planning process and the highly complex methods of delivery required for IMRT dose delivery. Important efforts are being made to define the required quality assurance for these computer-optimized IMRT plans and to find ways to reduce their complexity without reducing the quality of the resulting plans. By minimizing the complexity of these dose plans, one also minimizes the treatment time and the probability of dose delivery errors. Methods of optimization and evaluation of dose plans and practical considerations in inverse planning are discussed. In addition, this article points out the potential hazards of inverse-planned IMRT and discusses methods by which the complexity of these plans might be reduced. Copyright 2002, Elsevier Science (USA). All rights reserved.

Mesh:

Year:  2002        PMID: 12118386     DOI: 10.1053/srao.2002.32434

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  2 in total

Review 1.  Hypoxia imaging-directed radiation treatment planning.

Authors:  J G Rajendran; K R G Hendrickson; A M Spence; M Muzi; K A Krohn; D A Mankoff
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

Review 2.  Direct aperture optimization as a means of reducing the complexity of Intensity Modulated Radiation Therapy plans.

Authors:  Maria Broderick; Michelle Leech; Mary Coffey
Journal:  Radiat Oncol       Date:  2009-02-16       Impact factor: 3.481

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.